Yu‐Waye Chu

Anti-CD20/CD3 T cell–dependent bispecific antibody for the treatment of B cell malignancies

Liping Sun, Diego Ellerman, Mary Mathieu et al. · Science Translational Medicine · 2015 · 278 citations

Life Sciences, Hematology, Immunology +11

An anti-CD3/anti–CLL-1 bispecific antibody for the treatment of acute myeloid leukemia

Steven R. Leong, Siddharth Sukumaran, Maria Hristopoulos et al. · Blood · 2016 · 153 citations · Full text

Medicine, Hematology, Oncology +14

Catabolic Fate and Pharmacokinetic Characterization of Trastuzumab Emtansine (T-DM1): an Emphasis on Preclinical and Clinical Catabolism

Ben‐Quan Shen, Daniela Bumbaca, Ola M. Saad et al. · Current Drug Metabolism · 2012 · 137 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Mitigating the risk of cytokine release syndrome in a Phase I trial of CD20/CD3 bispecific antibody mosunetuzumab in NHL: impact of translational system modeling

Iraj Hosseini, Kapil Gadkar, Eric Stefanich et al. · npj Systems Biology and Applications · 2020 · 116 citations · Full text

Medicine, Immunology, Oncology +17

Exogenous insulin-like growth factor 1 enhances thymopoiesis predominantly through thymic epithelial cell expansion

Yu‐Waye Chu, Sabrina Schmitz, Baishakhi Choudhury et al. · Blood · 2008 · 111 citations · Full text

Life Sciences, Cell Biology, Immunology +14